Harvard Bioscience (HBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 94,135 | 112,250 | 113,335 | 118,904 | 102,100 |
| Cost of Goods | 39,369 | 46,179 | 52,516 | 51,252 | 44,059 |
| Gross Profit | 54,766 | 66,071 | 60,819 | 67,652 | 58,041 |
| Operating Expenses | 61,346 | 64,356 | 68,268 | 65,838 | 57,879 |
| Operating Income | -6,211 | 1,894 | -6,933 | 2,066 | 221 |
| Interest Expense | 3,209 | 3,591 | 2,548 | 1,540 | 4,831 |
| Other Income | -2,245 | -859 | 302 | -666 | -2,682 |
| Pre-tax Income | -11,665 | -2,556 | -9,179 | -140 | -7,292 |
| Income Tax | 740 | 859 | 337 | 148 | 518 |
| Net Income Continuous | -12,405 | -3,415 | -9,516 | -288 | -7,810 |
| Net Income | $-12,405 | $-3,415 | $-9,516 | $-288 | $-7,810 |
| EPS Basic Total Ops | -0.28 | -0.08 | -0.23 | -0.01 | -0.20 |
| EPS Basic Continuous Ops | -0.28 | -0.08 | -0.23 | -0.01 | -0.20 |
| EPS Diluted Total Ops | -0.28 | -0.08 | -0.23 | -0.01 | -0.20 |
| EPS Diluted Continuous Ops | -0.28 | -0.08 | -0.23 | -0.01 | -0.20 |
| EPS Diluted Before Non-Recurring Items | -0.07 | 0.06 | 0.03 | 0.18 | 0.07 |
| EBITDA(a) | $1,273 | $9,172 | $922 | $9,967 | $9,033 |